Home
News
Create
Screeners
Insights
Aarey Drugs & Pharmaceuticals
88.
33
-1.55
(-1.72%)
Market Cap
₹250.45 Cr
PE Ratio
74.31
Industry
Healthcare
Buy
Sell
Company Performance:
1D
-1.72%
1M
+41.37%
6M
-0.75%
1Y
+50.17%
5Y
+103.76%
View Company Insights
Latest news about Aarey Drugs & Pharmaceuticals
Aarey Drugs & Pharmaceuticals Submits SEBI Compliance Certificate for Q4 FY26
Apr 14, 2026
Aarey Drugs & Pharmaceuticals Limited submitted its Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 for Q4 FY26 ended March 31, 2026. The certificate, issued by registrar MUFG Intime India Private Limited, confirms proper handling of dematerialised securities and compliance with prescribed timelines. This regulatory filing demonstrates the pharmaceutical company's commitment to maintaining transparency and adherence to SEBI regulations.
Aarey Drugs & Pharmaceuticals Reports Q3FY26 Results with Revenue Decline
Feb 11, 2026
Aarey Drugs & Pharmaceuticals Announces Share Capital Increase and Preferential Issue Plans
Sep 06, 2025
Aarey Drugs & Pharmaceuticals Reports Q1 Results: Revenue Dips, Profit Rises
Aug 13, 2025
Get More Market Insights with
Heatmap
FII/DII
Company Filings
MF Holdings
Bulk/ Block Deals
Stock Rental via SLBM
Signals
MTF Insights
F&O Ban - MWPL
Top Deliveries
Market Valuation
IPO